Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Clin Oncol. 2011 Jun 1;29(16):2273-81. doi: 10.1200/JCO.2010.30.8304. Epub 2011 Jan 24.

How genetically engineered mouse tumor models provide insights into human cancers.

Author information

  • 1Memorial Sloan-Kettering Cancer Center, New York, NY, USA. katerina.politi@yale.edu

Abstract

Genetically engineered mouse models (GEMMs) of human cancer were first created nearly 30 years ago. These early transgenic models demonstrated that mouse cells could be transformed in vivo by expression of an oncogene. A new field emerged, dedicated to generating and using mouse models of human cancer to address a wide variety of questions in cancer biology. The aim of this review is to highlight the contributions of mouse models to the diagnosis and treatment of human cancers. Because of the breadth of the topic, we have selected representative examples of how GEMMs are clinically relevant rather than provided an exhaustive list of experiments. Today, as detailed here, sophisticated mouse models are being created to study many aspects of cancer biology, including but not limited to mechanisms of sensitivity and resistance to drug treatment, oncogene cooperation, early detection, and metastasis. Alternatives to GEMMs, such as chemically induced or spontaneous tumor models, are not discussed in this review.

PMID:
21263096
[PubMed - indexed for MEDLINE]
PMCID:
PMC3731923
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk